529
Views
15
CrossRef citations to date
0
Altmetric
Case Report

Home induction and outpatient treatment of kratom use disorder with buprenorphine-naloxone: A case report in a young adult

, PharmD, , MS, , MD, MPHORCID Icon & , MDORCID Icon

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Kirsten E. Smith, Kelly E. Dunn, David H. Epstein, Jeffrey D. Feldman, Albert Garcia-Romeu, Oliver Grundmann, Jack E. Henningfield, Christopher R. McCurdy, Jeffrey M. Rogers, Destiny Schriefer, Darshan Singh & Stephanie T. Weiss. (2022) Need for clarity and context in case reports on kratom use, assessment, and intervention. Substance Abuse 43:1, pages 1221-1224.
Read now

Articles from other publishers (13)

Bin Yang, Shanyong Yi, Ruiling Zhang & Mohammad Farris Iman Leong Abdullah. (2023) Adverse Psychological and Therapeutic Effects of Kratom (Mitragyna speciosa) Use: A Systematic Review. Malaysian Journal of Medicine and Health Sciences 19:5, pages 218-236.
Crossref
Husna Hassan, Nani Draman, Raihan Hassan, Norsiah Ali & Salziyan Badrin. (2023) The use of opioid in treating a patient with kratom use disorder: A case report. Electronic Journal of General Medicine 20:3, pages em482.
Crossref
Kirsten E. Smith, Jeffrey D. Feldman, Destiny Schriefer, Stephanie T. Weiss, Oliver Grundmann, Kelly E. Dunn, Darshan Singh, Christopher R. McCurdy, Gisela Butera & David H. Epstein. (2023) Diagnostic Ambiguities and Underuse of Clinical Assessment Tools: A Systematic Review of Case Reports on Kratom Addiction and Physical Dependence. Current Addiction Reports 10:2, pages 282-292.
Crossref
Kirsten E. Smith, Jeffrey M. Rogers, Kelly E. Dunn, Oliver Grundmann, Christopher R. McCurdy, Destiny Schriefer & David H. Epstein. (2022) Searching for a Signal: Self-Reported Kratom Dose-Effect Relationships Among a Sample of US Adults With Regular Kratom Use Histories. Frontiers in Pharmacology 13.
Crossref
Jeffrey M Rogers, Kirsten E Smith, Destiny Schriefer & David H Epstein. (2022) For Better or Worse: Self-reported Changes in Kratom and Other Substance Use as a Result of the COVID-19 Pandemic. Substance Abuse: Research and Treatment 16, pages 117822182211239.
Crossref
Catherine W Striley, Carolin C Hoeflich, Andrew T Viegas, Lindsey A Berkowitz, Emily G Matthews, Leyla P Akin, Chidinma Iheanyi-Okeahialam, Urmeen Mansoor & Christopher R McCurdy. (2022) Health Effects Associated With Kratom ( Mitragyna speciosa ) and Polysubstance Use: A Narrative Review . Substance Abuse: Research and Treatment 16, pages 117822182210958.
Crossref
Alessandro E. Vento, Simone de Persis, Sergio De Filippis, Fabrizio Schifano, Flavia Napoletano, John M. Corkery & Georgios D. Kotzalidis. (2021) Case Report: Treatment of Kratom Use Disorder With a Classical Tricyclic Antidepressant. Frontiers in Psychiatry 12.
Crossref
Stephanie T. Weiss & Heather E. Douglas. (2021) Treatment of Kratom Withdrawal and Dependence With Buprenorphine/Naloxone: A Case Series and Systematic Literature Review. Journal of Addiction Medicine 15:2, pages 167-172.
Crossref
Rosalind Gittins & Samantha Cole. (2021) Buprenorphine for the management of kratom dependency during covid-19: A case report. Drug Science, Policy and Law 7, pages 205032452110211.
Crossref
Mohammad Farris Iman Leong Bin Abdullah. (2020) Kratom Dependence and Treatment Options: A Comprehensive Review of the Literature. Current Drug Targets 21:15, pages 1566-1579.
Crossref
Pietro Brunetti, Alfredo Fabrizio Lo Faro, Anastasio Tini, Francesco Paolo Busardò & Jeremy Carlier. (2020) Pharmacology of Herbal Sexual Enhancers: A Review of Psychiatric and Neurological Adverse Effects. Pharmaceuticals 13:10, pages 309.
Crossref
Laura Flores-Bocanegra, Huzefa A. Raja, Tyler N. Graf, Mario Augustinović, E. Diane Wallace, Shabnam Hematian, Joshua J. Kellogg, Daniel A. Todd, Nadja B. Cech & Nicholas H. Oberlies. (2020) The Chemistry of Kratom [ Mitragyna speciosa ]: Updated Characterization Data and Methods to Elucidate Indole and Oxindole Alkaloids . Journal of Natural Products 83:7, pages 2165-2177.
Crossref
. (2019) Dexamfetamine. Reactions Weekly 1779:1, pages 102-102.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.